![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
01 Sanofi (8)
02 Biophore India Pharmaceuticals Pvt Ltd (1)
03 Dr. Reddy\'s Laboratories (2)
04 NanoAlvand (1)
05 Supriya Lifescience (1)
06 Naprod Life Sciences (1)
07 Accord healthcare (1)
08 Amneal Pharmaceuticals (1)
09 Arrotex Pharmaceuticals (2)
10 Aurobindo Pharma Limited (1)
11 Eugia Pharma (1)
12 GLAND PHARMA LIMITED (1)
13 Hetero Drugs (1)
14 JAMP PHARMA (1)
15 MSN Laboratories (1)
16 Meitheal Pharmaceuticals (1)
17 ORIFARM GROUP AS (1)
18 SEACROSS PHARMACEUTICALS (1)
19 Teva Pharmaceutical Industries (1)
20 Zydus Pharmaceuticals (1)
01 INJ (2)
02 INJEKTIONSVÄTSKA, LÖSNING (1)
03 Injection (3)
04 Injection fluid, resolution (2)
05 Liquid Injection (1)
06 Plerixafor 24Mg 1,2Ml 1 Unit Parenteral Use (1)
07 SOLUTION (3)
08 SOLUTION;SUBCUTANEOUS (9)
09 Solution for injection (2)
10 Vial (1)
11 Blank (4)
01 DISCN (1)
02 Generic (1)
03 Lead Market Dossiers- Filed (1)
04 Originator (1)
05 Prescription (3)
06 RX (8)
07 Blank (14)
01 Heterix 24 (1)
02 MOZOBIL (2)
03 Mozobil (7)
04 Neofor (1)
05 PLERIXAFOR (8)
06 PLERIXAFOR INJECTION (2)
07 Plerixafor ARX (2)
08 Plerixafor Accord (1)
09 Plerixafor Seacross (1)
10 Blank (4)
01 Australia (4)
02 Canada (3)
03 India (4)
04 Iran (1)
05 Italy (1)
06 Norway (4)
07 South Africa (2)
08 Sweden (1)
09 USA (9)